NDC 0065-0616-35 - Maxidex
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0065-0616
- Requested NDC
- 0065-0616-35
- Package NDCs from labels
- 0065-0616-35
- Manufacturer
- Alcon
- Effective date
- 2006-12-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Maxidex - Alcon | Alcon | 2006-12-26 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0065-0616-35 | Maxidex | 3.5 g in 1 TUBE | OINTMENT | 3.5 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| dexamethasone sodium phosphate | ACTIVE INGREDIENT | AI9376Y64P | MAXIDEX (DEXAMETHASONE SODIUM PHOSPHATE) OINTMENT [ALCON] | 1 | |
| dexamethasone phosphate | ACTIVE MOIETY | 2BP70L44PR | MAXIDEX (DEXAMETHASONE SODIUM PHOSPHATE) OINTMENT [ALCON] | 1 | |
| mineral oil | INACTIVE INGREDIENT | MAXIDEX (DEXAMETHASONE SODIUM PHOSPHATE) OINTMENT [ALCON] | 1 | ||
| white petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | MAXIDEX (DEXAMETHASONE SODIUM PHOSPHATE) OINTMENT [ALCON] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 6E79C53E-5BB9-31F8-DE1A-81B0BA2FD270 | 863fb43c-dd33-485b-9385-744db7a98b83 | 2006-12-26 | Warnings, Adverse reactions | 6E79C53E-5BB9-31F8-DE1A-81B0BA2FD270 863fb43c-dd33-485b-9385-744db7a98b83 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.